16.01.2015 11:30:00

CFO to leave RaySearch

Regulatory News:

RaySearch Laboratories AB (STO:RAYB) announces that Anders Martin-Löf, Chief Financial Officer of RaySearch, will leave the company in April to take up the CFO post at another company. Anders will retain his responsibilities as CFO until he leaves the company. A search for Anders’ successor is underway.

"Anders joined RaySearch in 2007 and has been our CFO since 2009. During that period RaySearch has been transformed strategically as we have fundamentally shifted business model, gone through a rapid international expansion and increased our revenues several hundred per cent. Anders has played an important role in this process and has contributed significantly to our success and to ensure a strong position going forward. I would like to thank him for all these years and wish him all the best for the future”, says Johan Löf, CEO of RaySearch.

About RaySearch

RaySearch Laboratories is a medical technology company that develops advanced software solutions for improved radiation therapy of cancer. RaySearch markets the RayStation® treatment planning system to clinics all over the world. In addition, RaySearch’s products are distributed through licensing agreements with leading medical technology companies such as Philips, Nucletron, IBA, Varian and Brainlab. To date, 15 products have been launched via partners and RaySearch’s software is used by over 2,500 clinics in more than 65 countries. RaySearch was founded in 2000 as a spin-off from Karolinska Institute in Stockholm and the company is listed in the Small Cap segment on Nasdaq Stockholm.

For more information about RaySearch, visit www.raysearchlabs.com

This information was brought to you by Cision http://news.cision.com

Analysen zu RaySearch Laboratories AB (B)mehr Analysen

Eintrag hinzufügen
Hinweis: Sie möchten dieses Wertpapier günstig handeln? Sparen Sie sich unnötige Gebühren! Bei finanzen.net Brokerage handeln Sie Ihre Wertpapiere für nur 5 Euro Orderprovision* pro Trade? Hier informieren!
Es ist ein Fehler aufgetreten!

Aktien in diesem Artikel

RaySearch Laboratories AB (B) 19,64 1,45% RaySearch Laboratories AB (B)